"Once the patient is under anesthesia, and is completely asleep, I put a little small camera through the urethra, into the ...
A pulmonologist at the Cleveland Clinic shares the lung cancer warning signs he looks for in his own body. The deadly disease ...
New compound fragment disables cancer cells’ antioxidant defenses, paving the way for a next-generation treatment strategy ...
This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating a 34-day-plus record set ...
Achieved record-high quarterly revenues, Adjusted EBITDA 1 and Adjusted EBITDA per share 1 since inception Increased 2025 financial guidance ...
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...
The Kanazawa team led by Katsuya Sakai, discovered that CHD1 uses a flexible region to form tiny liquid-like droplets, called condensates, that act as hubs for controlling the activity of crucial ...
Recorded third quarter 2025 worldwide revenue of $384.0 million, GAAP fully diluted earnings per share of $0.41, adjusted fully diluted earnings per share of $1.27 and free cash flow of $94.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback